- www.okbfoundation.org/Our Impact/Donate
AdHealthcare at your doorsteps - Transforming lives in Africa
We provide transformative healthcare services to underserved Ghanaians. We bring healthcare to the doorsteps of underserved communities in Ghana
Search results
Oct 2, 2020 · Background Screening of unvaccinated women remains essential to mitigate the high morbidity/mortality of cervical cancer. Here, we compared visual inspection with acetic acid (VIA), recommended by WHO as the most cost-effective screening approach in LMICs, with HPV-based screening, and usage of p16INK4a/Ki-67 dual stain cytology. Methods We prospectively enrolled women participating in a VIA ...
Mar 11, 2024 · Roche's cervical cancer portfolio includes the cobas HPV Test, used for primary screening and co-testing, which tests for 14 types of high-risk HPV genotypes in cervical cancer.
For women with a previous negative HPV screening test, the screening interval is 5 years if <45 years and 10 years for women aged >= 45. For women 45 years or older with a positive HPV test but with double negative cytology triage, the next invitation will be sent after 5 years instead of after 10 years.
Jun 25, 2020 · In March 2020, the manual dual-stain cytology test was approved by the U.S. Food and Drug Administration (FDA) for women who have received a positive result on a primary HPV screening. The manual ...
Oct 2, 2020 · The utility of p16INK4a/Ki-67 dual stain cytology as a triage test for HPV positive women in LMICs should be further studied. ... Cervical cancer is the leading cause of mortality by cancer in sub ...
May 13, 2019 · Triage of human papillomavirus–positive women with dual stain may lead to lower referral to undergo colposcopy with similar detection of precancerous lesions compared with cytologic screening, making cervical cancer screening more efficient. Key Points Question What are efficient approaches for triage of human papillomavirus–positive women in cervical cancer screening? Findings This cohort ...
Jun 4, 2024 · In a real-world Swedish cohort of 28,017 women, screening for cervical cancer using a DNA methylation-based tool, the WID-qCIN test, either alone or in combination with HPV16/18 genotyping, showed ...
